ClinicalTrials.govpublic full text
Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma
recurrent adult hodgkin lymphoma, recurrent childhood hodgkin lymphoma, refractory childhood hodgkin lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807850
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.